The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling

被引:60
|
作者
Charest, Pascale G.
Oligny-Longpre, Genevieve
Bonin, Helene
Azzi, Mounia
Bouvier, Michel
机构
[1] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada
[2] Univ Montreal, Grp Rech Univ Med, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada
[3] Neurochem Inc, Laval, PQ H7V 4A7, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
V2 vasopressin receptor; GPCR; extra-cellular signal-regulated kinases 1 and 2; MAPK; beta arrestin;
D O I
10.1016/j.cellsig.2006.05.020
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The V2 vasopressin receptor (V2R) activates the mitogen activated protein kinases (MAPK) ERK 1/2 through a mechanism involving the scaffolding protein beta arrestin. Here we report that this activating pathway is independent of G alpha s, G alpha i, G alpha q or G beta alpha and that the V2R-mediated activation of G alpha s inhibits ERKI/2 activity in a cAMP/PKA-dependent manner. In the HEK293 cells studied, the beta arrestin-promoted activation was found to dominate over the PKA-mediated inhibition of the pathway, leading to a strong vasopressin-stimulated ERK1/2 activation. Despite the strong MAPK activation and in contrast with other GPCR, V2R did not induce any significant increase in DNA synthesis, consistent with the notion that the stable interaction between V2R and beta arrestin prevents signal propagation to the nucleus. beta arrestin was found to be essential for the ERK1/2 activation, indicating that the recruitment of the scaffolding protein is necessary and sufficient to initiate the signal in the absence of any other stimulatory cues. Based on the use of selective pharmacological inhibitors, dominant negative mutants and siRNA, we conclude that the beta arrestin-dependent activation of ERKI/2 by the V2R involves c-Src and a metalloprotemase-dependent trans-activation event. These findings demonstrate that beta arrestin is a genuine signalling initiator\that can, on its own, engage a MAPK activation machinery upon stimulation of a GPCR by its natural ligand. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:32 / 41
页数:10
相关论文
共 50 条
  • [1] Vasopressin V2 receptor, tolvaptan, and ERK1/2 phosphorylation in the renal collecting duct
    Khan, Shaza
    Raghuram, Viswanathan
    Chen, Lihe
    Chou, Chung-Lin
    Yang, Chin-Rang
    Khundmiri, Syed J.
    Knepper, Mark A.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2024, 326 (01) : F57 - F68
  • [2] Arrestin-dependent activation of ERK1/2 by the V2 vasopressin receptor is influenced by its palmitoylation state
    Charest, P
    Azzi, M
    Bouvier, M
    FASEB JOURNAL, 2002, 16 (04): : A148 - A149
  • [3] Palmitoylation of the V2 vasopressin receptor carboxyl tail enhances β-arrestin recruitment leading to efficient receptor endocytosis and ERK1/2 activation
    Charest, PG
    Bouvier, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (42) : 41541 - 41551
  • [4] Vasopressin/V2 receptor stimulates renin synthesis in the collecting duct
    Gonzalez, Alexis A.
    Cifuentes-Araneda, Flavia
    Ibaceta-Gonzalez, Cristobal
    Gonzalez-Vergara, Alex
    Zamora, Leonardo
    Henriquez, Ricardo
    Rosales, Carla B.
    Navar, L. Gabriel
    Prieto, Minolfa C.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2016, 310 (04) : F284 - F293
  • [5] β-arrestin engagement by the insulin-like growth factor receptor is required for V2 vasopressin receptor-promoted ERK1/2 activation
    Oligny-Longpre, G.
    Bouvier, M.
    FEBS JOURNAL, 2008, 275 : 316 - 316
  • [6] Low pH stimulates vasopressin V2 receptor promoter activity and enhances downregulation induced by V1a receptor stimulation
    Memetimin, Hasiyet
    Izumi, Yuichiro
    Nakayama, Yushi
    Kohda, Yukimasa
    Inoue, Hideki
    Nonoguchi, Hiroshi
    Tomita, Kimio
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2009, 297 (03) : F620 - F628
  • [7] Engagement of β-arrestin by transactivated insulin-like growth factor receptor is needed for V2 vasopressin receptor-stimulated ERK1/2 activation
    Oligny-Longpre, Genevieve
    Corbani, Maithe
    Zhou, Joris
    Hogue, Mireille
    Guillon, Gilles
    Bouvier, Michel
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (17) : E1028 - E1037
  • [8] Vasopressin V2 receptor antagonists
    Wong, LL
    Verbalis, JG
    CARDIOVASCULAR RESEARCH, 2001, 51 (03) : 391 - 402
  • [9] V2 vasopressin receptor mutations
    Makita, Noriko
    Manaka, Katsunori
    Sato, Junichiro
    Iiri, Taroh
    VASOPRESSIN, 2020, 113 : 79 - 99
  • [10] Phosphorylation of the V2 vasopressin receptor
    Innamorati, G
    Sadeghi, H
    Eberle, AN
    Birnbaumer, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (04) : 2486 - 2492